BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 16785188)

  • 1. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
    Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
    Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
    Collins BJ; Spence RA; Ferguson R; Laird J; Love AH
    Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of bolus and continuous nasogastric feeding on gastro-oesophageal reflux and gastric emptying in healthy volunteers: a randomised three-way crossover pilot study.
    Bowling TE; Cliff B; Wright JW; Blackshaw PE; Perkins AC; Lobo DN
    Clin Nutr; 2008 Aug; 27(4):608-13. PubMed ID: 18513835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates.
    Reddy PS; Deorari AK; Bal CS; Paul VK; Singh M
    Indian Pediatr; 2000 Aug; 37(8):837-44. PubMed ID: 10951632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects.
    Zerbib F; des Varannes SB; Roman S; Pouderoux P; Artigue F; Chaput U; Mion F; Caillol F; Verin E; Bommelaer G; Ducrotté P; Galmiche JP; Sifrim D
    Aliment Pharmacol Ther; 2005 Nov; 22(10):1011-21. PubMed ID: 16268977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cisapride on abnormally prolonged endogastric alkalinity time and delayed gastric emptying in cirrhotic patients.
    Pimpo MT; Frieri G; Saltarelli P; Ciccocioppo R; Aggio A; Marchetti G; Taddei G; Carlei F; Lygidakis NJ; Onori L
    Hepatogastroenterology; 1996; 43(12):1678-84. PubMed ID: 8975988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.
    Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO
    Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients.
    Emerenziani S; Habib FI; Ribolsi M; Caviglia R; Guarino MP; Petitti T; Cicala M
    Aliment Pharmacol Ther; 2006 Mar; 23(6):751-7. PubMed ID: 16556177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.
    Gardner JD; Rodriguez-Stanley S; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1819-29. PubMed ID: 12269977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the mechanism of gastro-oesophageal reflux and oesophageal acid exposure in patients with reflux disease.
    Scheffer RC; Wassenaar EB; Herwaarden MA; Holloway RH; Samsom M; Smout AJ; Akkermans LM
    Neurogastroenterol Motil; 2005 Oct; 17(5):654-62. PubMed ID: 16185303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial oesophageal integrated acidity is a reliable predictor of gastro-oesophageal reflux disease.
    Shih GL; Brensinger CM; Katzka DA; Metz DC
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1475-82. PubMed ID: 15948815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myoelectric activity of the stomach and esophageal pH changes in reflux disease].
    Banach T; Ciećko-Michalska I; Cibor D; Szulewski P; Bogdał J; Thor PJ
    Folia Med Cracov; 2001; 42(1-2):53-61. PubMed ID: 11712326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twelve months' follow-up after treatment with the EndoCinch endoscopic technique for gastro-oesophageal reflux disease: a randomized, placebo-controlled study.
    Montgomery M; Håkanson B; Ljungqvist O; Ahlman B; Thorell A
    Scand J Gastroenterol; 2006 Dec; 41(12):1382-9. PubMed ID: 17101568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
    McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
    Roman S; Serraj I; Damon H; Mion F
    Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
    Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux disease.
    Conchillo JM; Schwartz MP; Selimah M; Samsom M; Arts J; Tack J; Sifrim D; Smout AJ
    Aliment Pharmacol Ther; 2007 Jul; 26(1):61-8. PubMed ID: 17555422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal gastric acidity pattern in gastro-oesophageal reflux disease with or without oesophagitis.
    Sozzi M; Valentini M; Poletti M; Bertolissi E; Serraino D; Bovero E; De Iaco F
    Ital J Gastroenterol; 1995; 27(8):413-8. PubMed ID: 8775466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.